The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma)

Sadeleştirilmiş öğe sayfası
dc.contributor.authorLaver, Lior
dc.contributor.authorFilardo, Giuseppe
dc.contributor.authorSanchez, Mikel
dc.contributor.authorMagalon, Jeremy
dc.contributor.authorTischer, Thomas
dc.contributor.authorAbat, Ferran
dc.contributor.authorBastos, Ricardo
dc.contributor.authorCugat, Ramon
dc.contributor.authorIosifidis, Micahel
dc.contributor.authorKocaoglu, Baris
dc.contributor.authorKon, Elizaveta
dc.contributor.authorMarinescu, Rodica
dc.contributor.authorOstojic, Marko
dc.contributor.authorBeaufils, Philippe
dc.contributor.authorde Girolamo, Laura
dc.contributor.authorESSKA ORBIT Grp
dc.date.accessioned2025-10-16T15:13:40Z
dc.date.issued2024
dc.identifier.doi10.1002/ksa.12077
dc.identifier.otherWOS:001178770700001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5902
dc.publisherWILEY
dc.sourceKNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY
dc.subjectDelphi consensus
dc.subjectknee
dc.subjectinjections
dc.subjectorthobiologics
dc.subjectosteoarthritis
dc.subjectplatelet\\-rich plasma
dc.titleThe use of injectable orthobiologics for knee osteoarthritis: A European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma)
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS